# Imaging of Solid Tumors Using FAP-2286

> **NCT04621435** · PHASE1 · RECRUITING · sponsor: **Thomas Hope** · enrollment: 191 (estimated)

## Conditions studied

- Solid Tumors, Adult
- Metastatic Cancer

## Interventions

- **DRUG:** Gallium-68 labelled (68Ga-) FAP-2286
- **PROCEDURE:** Positron Emission Tomography (PET) imaging
- **DRUG:** Copper-64 labeled (64Cu-) FAP-2286

## Key facts

- **NCT ID:** NCT04621435
- **Lead sponsor:** Thomas Hope
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-14
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 191 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621435, "Imaging of Solid Tumors Using FAP-2286". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04621435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*